Genesem Approves Director Compensation Limit of 2 Billion Won at Temporary Shareholders Meeting; Limited Impact on Shareholder Value

Genesem held a temporary shareholders meeting on June 19, 2026 at its Songdo headquarters in Incheon, approving both the director compensation limit of 2 billion won and the adoption of director compensation regulations as originally proposed.
The compensation limit increased by 500 million won from the previous maximum of 1.5 billion won, but the actual payment last year was only 1.482 billion won, limiting the cost increase and reducing concerns over shareholder value impairment.
The director compensation regulations include stock-based compensation such as stock options, which could lead to future dilution, but no specific issuance plan has been disclosed yet.
The company is a KOSDAQ venture firm with total assets under 100 billion won and is exempt from appointing outside directors; the board consists of four inside directors, which is a minor governance concern.
[AI Summary]This disclosure represents a routine adjustment of the compensation system and is neither particularly positive nor negative. The increase in the compensation limit is insignificant relative to market capitalization, and actual payments have been within the previous limit, limiting negative impact on shareholder value. However, potential dilution from stock-based compensation warrants future monitoring.